Infant Bacterial Therapeutics AB (publ) reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was SEK 19.2 million compared to net income of SEK 0.451 million a year ago. Basic loss per share from continuing operations was SEK 1.71 compared to basic earnings per share from continuing operations of SEK 0.04 a year ago.